Key changes and updates to the 2025 European Association of Urology recommendations on urological infections | Ukrainian Medical Journal

In light of the updated recommendations of the European Association of Urology (EAU) 2025, significant attention has been paid to improving the classification of urinary tract infections (UTIs), as well as finding alternatives to traditional antibiotic therapy in the context of increasing antibiotic resistance. The new approach to the classification of UTIs, based on the distinction between localized and systemic infections, allows for a more accurate determination of the severity of the disease and the selection of appropriate treatment tactics. Non-antibacterial therapy for cystitis occupies a special place in the recommendations. A systematic review of the literature conducted in 2024 confirmed the effectiveness of herbal remedies both in the acute phase and in the prevention of relapses. The data obtained were included in the new section 3.4.4.1 of the EAU guidelines and summarized in the summary of evidence in subsection 3.4.4.1.4. This emphasizes the relevance of the use of herbal medicines as part of a personalized approach to the treatment of cystitis, aimed at reducing the use of antibiotics and combating the spread of resistant bacterial strains.

References

1. Bonkat G., Wagenlehner F., Cai T. et al. (2025) Classification of Urinary Tract Infections in 2025: Moving Beyond Uncomplicated and Complicated. European Urology Open Science, 75: 44–47. doi: 10.1016/j.euros.2025.03.010.
2. Bonkat G., Kranz J., Cai T. et al. (2025) European Association of Urology Guidelines on Urological Infections.
3. Barbosa-Cesnik C., Brown M.B., Buxton M. et al. (2011) Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin. Inf. Dis., 52: 23–30. doi: 10.1093/cid/ciq073.
4. Little P., Turner S., Rumsby K. et al. (2009) Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technology Assessment, 13(19): 1–73. doi: 10.3310/hta13190.
5. Sengupta K., Alluri K.V., Golakoti T. et al. (2011) A Randomized, Double Blind, Controlled, Dose Dependent Clinical Trial to Evaluate the Efficacy of a Proanthocyanidin Standardized Whole Cranberry (Vaccinium macrocarpon) Powder on Infections of the Urinary Tract. Current Bioactive Compound, 7: 39–46. doi: 10.2174/157340711795163820.
6. Parazzini F., Ricci E., Fedele F. et al. (2022) Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed. Rep., 17(2): 69. doi: 10.3892/br.2022.1552.
7. Wagenlehner F.M., Abramov-Sommariva D., Höller M. et al. (2018) Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial. Urologia Internationalis, 101(3): 327–336. doi: 10.1159/000493368.
8. Gupta V., Mastromarino P., Garg R. (2024) Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial. Clin. Inf. Dis., 78(5): 1154–1161. doi: 10.1093/cid/ciad766.
9. Tsiakoulias E., Gravas S., Hadjichristodoulou C. et al. (2024) Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis. World J. Urology, 42(1): 27. doi: 10.1007/s00345-023-04741-0.
10. Hayward G., Mort S., Hay A.D. et al. (2024) d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. JAMA Intern. Med., 184(6): 619–628. doi: 10.1001/jamainternmed.2024.0264.
11. Cai T., Anceschi U., Tamanini I. et al. (2021) Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis. Antibiotics (Basel)., 11(1): 14. doi: 10.3390/antibiotics11010014.
12. van Wietmarschen H., van Steenbergen N., van der Werf E. et al. (2022) Effectiveness of herbal medicines to prevent and control symptoms of urinary tract infections and to reduce antibiotic use: A literature review. Integrat. Med. Res., 11: 100892. doi: 10.1016/j.imr.2022.100892.
13. Sabadash M., Shulyak A. et al. (2017) Canephron® N in the treatment of recurrent cystitis in women of child-bearing Age: a randomised controlled study. Clini. Phytosci., 3: 9. doi: 10.1186/s40816-017-0046-7.
14. Hudson R.E., Job K.M., Sayre C.L. et al. (2022) Examination of Complementary Medicine for Treating Urinary Tract Infections Among Pregnant Women and Children. Front. Pharmacol., 13: 883216. doi: 10.3389/fphar.2022.883216.
15. mozdocs.kiev.ua/likiview.php?id=4974.